MedTrace Logo

Paracetamol Discontinuation in the Elderly After Long-term Consumption

NCT04523740 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2020-08-25

No results posted yet for this study

Summary

To investigate if long-term treatment of paracetamol can be discontinued without no worsening on pain, health-related quality-of-life and level of function compared to continuing paracetamol treatment in patients aged 65 years or more.

Conditions

  • Pain, Chronic
  • Pain, Medication
  • Pain, Discontinuation

Interventions

DRUG

Placebo

Patients who use regular paracetamol will now receive 6 to 8 tablets of placebo per day for 2 weeks

DRUG

Paracetamol

Patients who use regular paracetamol will now receive 6 to 8 tablets of 500 mg paracetamol per day for 2 weeks

Sponsors & Collaborators

  • University Hospital Bispebjerg and Frederiksberg

    lead OTHER

Principal Investigators

  • Jon T Andersen, MD, PhD · Department of Clinical Pharmacology

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04523740 on ClinicalTrials.gov